Motivation: The pathogenesis of AD is complex and contributed by both genetic and environmental factors. Recent work revealed a potential link between DNA methylation and AD. However, a genomewide study to identify potential DNA methylation sites involved in AD is still at an early stage. WGBS, an up-to-date technology, was used in this study. We investigated mouse brain genome-wide DNA methylation profiles between seven-month-old SAMP8 and SAMR1 models through deep WGBS. Results: According to the results, the global ML slightly decreased in the SAMP8 mice than in the SAMR1 mice (4.12% versus 4.19%). A total of 1 307 172 280 clean reads were obtained. Subsequently, we identified 63 DMRs from all cases in SAMP8 mice relative to SAMR1 mice. In addition, 26 DMR-related genes were detected. GO analyses revealed that these DMR-related genes were involved in regulating the development of AD from different aspects. Finally, three differentially expressed DMR-related genes (Dlgap1, TMEM51 and Eif2ak2) that were most likely involved in AD were summarized and listed in detail. Our study provided a systematic exploration of DNA methylation profiles in SAMP8 mouse brain for the first time. These novel methylation sites may be considered strong future candidates to combat this life-threatening disease. Availability and Implementation: The WGBS sequencing clean data and RNA-seq clean data have been deposited in the NCBI Sequence Read Archive (SRA).The accession number of WGBS is SRP097054. The accession number of RNA-seq is SRP096779.
Introduction
Epigenetic modification is a dynamic process influenced by external environmental factors and predetermined inherited programs (Huang et al., 2014) . One of the most widely investigated modes of epigenetic regulation is DNA methylation, which refers to the addition of a methyl group at the fifth position of cytosine in DNA (He et al., 2011) . As an important phenomenon in mammals, DNA methylation has been implicated in diverse processes, including X chromosome inactivation, embryogenesis, genomic imprinting, transposon silencing and diseases (Yang et al., 2016) . This consistent progress gives us great confidence and encourages us to explore the role of DNA methylation in a deeper level. Alzheimer's disease (AD), the most common dementia in the elderly, is a progressive degenerative brain disorder (Rocchi et al., 2009) . Two pathological hallmarks are observed in AD patients, namely, NFTs and Ab (Hayne et al., 2014) . However, the protocols targeting NFTs and Ab have been unsuccessful (Lee et al., 2015) , possibly because of the correlation with the elusive etiology of AD. Therefore, further insights are needed for AD therapy. Recent research has shifted focus to dysregulated DNA methylation in AD. Evidence revealed that the global DNA methylation status in entorhinal cortex layer II neurons is significantly diminished in AD (Mastroeni et al., 2010) . The DNA methylation array showed that the promoter hypermethylation for Tbxa2r, F2rl2, Sorbs3 and Spnb4 in the frontal cortex of the APP-PSEN1 and 3xTg-AD models is involved in AD-associated signaling pathways and cellular structures (Sanchez-Mut et al., 2013) . Despite all these findings, our understanding of disordered DNA methylation patterns in AD remains limited.
In this study, we investigated DNA methylation profiles in the brain of senescence-accelerated mouse prone 8 (SAMP8) and senescence-accelerated mouse resistant 1 (SAMR1) mice at the seven-month-old stage using whole genome bisulfite sequencing (WGBS) technology. The SAMP8 strain, which shares behavioral, cognitive and neuropathological alterations observed in AD patients, is a plausible natural model for exploring the pathogenesis of AD (Kang et al., 2014) . The SAMR1 strain is often used as the control group. Compared with methylated DNA binding domain sequencing, reduced representation bisulfite sequencing, and methylated DNA immunoprecipitation sequencing, WGBS achieves singlebase resolution and does not have a preference (Dolzhenko and Smith, 2014) . Obviously, WGBS is the most effective channel to study genomic methylation patterns. Our research systematically analyzed DNA methylation patterns potentially involved in AD. Valuable resources are provided to develop therapeutic targets or novel diagnostics.
Methods

Animal and tissue collection
Experimental male SAMR1 mice (1 month, n ¼ 22) and SAMP8 mice (1 month, n ¼ 22) were purchased from Beijing WTLH Biotechnology Co., Ltd. The mice were housed under standard conditions until seven months old. We randomly selected 7 animals from each group to collect the cerebral cortex. These tissues were immediately frozen in liquid nitrogen for WGBS and RNA sequencing. In addition, 12 animals in each group were also randomly selected for the morris water maze (MWM) task.
This study was followed the 'Guide for the care and use of laboratory animals' (Clark et al., 1997) .
MWM test
We evaluated the spatial learning and memory ability of the mice using the MWM test. The detailed method was described in Supplementary Material S1.
2.3 WGBS library preparation, sequencing, quality analysis and mapping The detailed methods were described in Supplementary Material S2.
Non-CG methylation sequence motifs
Custom python scripts were applied to retrieve sequence motifs (4 bp upstream and 5 bp downstream of the methylated site). The sequence logos were built by WebLogo3.3.
Estimating methylation level (ML)
The detailed steps were described in Supplementary Material S3.
Identification of differentially methylated regions (DMRs)
The detailed method was described in Supplementary Material S4.
GO enrichment analyses of WGBS
GO enrichment analysis was applied to genes related to DMRs by the GOseq R package (Young et al., 2010) . GO terms with P < 0.05 were considered significantly enriched.2.8 RNA sequencing
The detailed method was described in Supplementary Material S5.
Bisulfite sequencing PCR (BSP) and qPCR
The specific BSP and quantitative primers are listed in Supplementary  Tables S1 and S2 . The detailed procedures were described in Supplementary Material S6.
Statistical analysis
The data are presented as the mean 6 SEM. The escape latency in the MWM test was compared by applying two-way ANOVA. Student's t-test was used to compare the qPCR results and remaining data of the MWM test. The differences between the groups were considered significant at P < 0.05.
Results
Cognitive dysfunction in the SAMP8 mice
Compared with the SAMR1 mice, the seven-month old SAMP8 mice took a significantly longer time to find the platform (P < 0.05, Supplementary Fig. S1A ). Supplementary Figure S1B showed that the SAMP8 mice swam randomly in the tank without knowing the target location. The number of crossings of the SAMP8 mice was significantly reduced compared with that of the SAMR1 mice (P < 0.05, Supplementary Fig. S1C ). Furthermore, the SAMR1 mice spent more time in the target quadrant than the SAMP8 mice (P < 0.05, Supplementary Fig. S1D ). The swimming speed in the visible platform test did not significantly differ between the two groups (P > 0.05, Supplementary Fig. S1E ). This result suggested that the altered exploration of the SAMP8 mice was not due to motor or visual dysfunction. These data revealed that the seven-month-old SAMP8 mice had severe learning and memory impairments, which are the core clinical features observed in AD patients.
WGBS roundup
A total of 1 307 172 280 clean reads were obtained. These reads were detected in all chromosomal regions in each group ( Supplementary Fig. S2 ). The mapping rates were 75.64% and 71.85% in the SAMR1 and SAMP8 mice, respectively. The mapped reads were used for subsequent analysis.
Subsequently, we calculated the ML of each cytosine. Table  S3 ). The classification of mCs showed a similar proportion between the two groups. The percentages of mCs were approximately 62% mCG, 32% mCHH and 6% mCHG (Supplementary Fig. S3 ). Sequence analysis showed a dominant CAC sequence motif for the CHH methylated sites, which was consistent with previous findings in mammals (Guo et al., 2014) . By contrast, the CHG methylated sites focused mostly on the CAG sequence motif (Fig. 1) .
Furthermore, we divided the gene into specific gene features: promoter, TSS, 5 0 UTR, exons, introns, and 3 0 UTR. The MLs were evaluated in these functional regions. As shown in Figure 2 , the MLs in specified regions of the two groups were similar. Promoter showed a decreasing ML toward the TSS. The lowest MLs were detected in the TSS and 5 0 UTR regions but increased within the exons and introns. Moreover, the MLs were higher in the introns than in the exons. The 3 0 UTR showed a similar pattern to the exons. In addtion, the more detailed data was listed in Supplementary Table S4 .
The loss of genomic DNA methylation has been observed in various common human age-related diseases (Bollati et al., 2009) . In the present study, the global ML slightly decreased in the SAMP8 mice (4.12%) than in the SAMR1 mice (4.19%). This alteration implied the potential role of DNA methylation in AD regulation.
DMRs between SAMP8 and SAMR1
A total of 63 DMRs were detected between the two groups, including 41 Hyper (hypermethylation in SAMP8 mice compared with SAMR1 mice) DMRs and 22 Hypo (hypomethylation in SAMP8 mice compared with SAMR1 mice) DMRs (P < 0.05, Supplementary Table  S5 ). Cluster analysis of DMRs was conducted using a heat map between SAMP8 and SAMR1 strains (Fig. 3) .
BSP confirmation
As shown in Supplementary Figure S4 , all of the selected regions were detected between SAMP8 and SAMR1 mice. Taken together, there was a high level of consistency between BSP results and WGBS data.
Functional enrichment analysis: gene ontology (GO)
We determined that 24 out of 63 DMRs corresponded to 26 protein-coding genes (Supplementary Table S6 ). Through GO survey, 124 GO terms were significantly enriched (P < 0.05, Supplementary Table S7) . Importantly, AD-associated terms were observed, for example, glial cell apoptotic process (GO: 0034349). Our findings suggested that specific genes could be regulated by DNA methylation involved in AD.
Differential expression analysis of mRNAs
Using RNA sequencing technique, a total of 2505 significantly differentially expressed mRNA transcripts were identified; 1019 were downregulated, whereas 1486 were upregulated in the SAMP8 mice (P < 0.05, Supplementary Table S8).
qPCR confirmation
As a result, all of the selected transcripts were detected and exhibited significant differential expression between the SAMP8 and SAMR1 mice ( Supplementary Fig. S5 ). The qPCR results were consistent with the RNA sequencing data.
Correlation analysis
We set three limiting factors to deepen our understanding on the relationship between DNA methylation and AD. The first factor was that the gene should be significantly differentially expressed between the SAMP8 and SAMR1 mice. The second was that the gene was a DMR-related gene. The last requirement was that the selected gene may be involved in the pathophysiological process of AD. Following the above three steps, three fulfilled genes were detected. Dlgap1, one of the SAP90/PSD95-associated protein genes, is specifically expressed in neuronal cells. We found that the expression of Dlgap1-016 (one of the alternatively spliced transcripts of Dlgap1) in the SAMP8 mice was significantly higher than that in the SAMR1 mice. By contrast, Dlgap1 exhibited different MLs in the specific intron region of the two groups. The specific intron area of TMEM51 was hypermethylated in the SAMP8 mice than in the SAMR1 mice. Moreover, TMEM51 showed a significantly high expression in the SAMP8 mice. Finally, Eif2ak2 was also a qualified candidate. More detailed results are listed in Table 1 . We predicted that these three DMR-related genes were most probably involved in the adjustment of AD.
Discussion
At present, no treatments can reverse or stop AD progression, even though some may temporarily improve symptoms (Burns and Iliffe, 2009) . Multiple causes participate in the pathogenesis of AD, including aging, genetic variables and environmental factors. Epigenetics is emerging as an important link to provide mechanistic insights into genetic and environmental risk factors for the disease, thereby arousing great concern. DNA methylation, the main focus of epigenetic modification, has been proven to be related to AD (Lu et al., 2013) . Previous studies provided several considered but underdeveloped clues. WGBS, which allows for unbiased genomewide DNA methylation profiling, has allowed us to investigate ADrelated DNA methylation in unprecedented detail. In the present study, SAMP8, a naturally derived model, was used to understand the DNA methylation profiles in AD. Research indicated that sevenmonth-old SAMP8 mice showed age-related spontaneous deterioration in learning and memory abilities, preceded or accompanied with pathological features that are similar to AD patients (Kang et al., 2014) . Results of our MWM experiment were also consistent with their findings. SAMP8 mice are considered a model of AD at the age of seven months. Therefore, we extensively analyzed the DNA methylation profiles in the SAMP8 mice brain using WGBS. Our findings might provide a novel molecular strategy to profoundly affect the diagnosis and therapy of AD in the future. Previous research indicated that mCs not only occur in CpG dinucleotides but also in the extensive non-CpG regions of the mammalian genome (Yuan et al., 2016) . In our study, 28 506 306 mCG, 14 475 288 mCHH and 2 771 077 mCHG were detected in the SAMP8 mice. Compared with the CpG dinucleotide, non-CpG can be considered an alternative form of methylation. Kinde et al. reported that both CpG and non-CpG methylation play key roles in the nervous system (Kinde et al., 2015) . We predicted that these mCs may be involved in AD pathogenesis. Besides, SAMR1 showed a similar but increased ML compared with the SAMP8 strain. This phenomenon was consistent with previous human studies (Bollati et al., 2009) and strong evidence of the close relationship between DNA methylation and AD.
A total of 63 significant DMRs were observed. Upon further investigation, 26 genes corresponding to 24 DMRs were predicted, such as the Prkca gene plays a key role in determining the magnitude of the Tcell proliferative response upon T-cell activation (Barton et al., 2004) . The Gldc gene provides instructions for making an enzyme called glycine dehydrogenase, and participates in the regulation of diseases, for example, non-small cell lung cancer tumor (Zhang et al., 2012) . Research shows Mn1 overexpression is frequently observed in patients with acute myeloid leukemia (AML) and is predictive of poor prognosis (Riedel et al., 2016) . In our study, these DMRs mainly remained in the gene body regions rather than the promoters. We predicted that the intragenic methylated site was possibly correlated with gene expression involved in the pathological process of AD. According to reports, DNA methylation and gene expression in mammals exhibit different features: 1) gene silencing is related to the hypermethylation of its promoter (Zuo et al., 2007) ; and 2) high levels of gene expression are often associated with elevated gene body methylation (Cokus et al., 2008) . However, studies also revealed that methylation in the gene body may suppress gene expression (Jin et al., 2013) . Our data suggested that methylation in the gene body promoted gene expression, but it could also reduce gene expression. Moreover, GO functional annotation analysis in our study showed that these DMR-related genes were enriched in AD pathogenesis. Unquestionably, a close relationship was observed between these DMR-related genes and AD.
Strict conditions were followed to select the most likely DMRrelated genes involved in the regulation of AD pathogenesis. Eventually, we identified three eligible genes. The methylation of Dlgap1 and TMEM51 was upregulated within the intron region; their expression levels were also upregulated. Meanwhile, the methylation of Eif2ak2 was upregulated within the intron region but its expression was downregulated in the SAMP8 mice compared with the SAMR1 mice. Recent evidence showed the involvement of intragenic DNA methylation in the regulation of alternative splicing (Zheng et al., 2016) . Dlgap1 was specifically expressed in neuronal cells and enriched in the PSD fraction. Dlgap1 might have potential activity to maintain the structure of PSD (Takeuchi et al., 1997) . One of the Dlgap1 transcripts (Dlgap1-016) showed high expression in the SAMP8 mice, which might be associated with AD risk through DNA methylation. The promoter of TMEM59 presents a low methylation status in AD cases (Bakulski et al., 2012) . In this study, the intron of TMEM51 showed high methylation status leading to overexpression in the SAMP8 mice. TMEM51 might be regarded as a new DNA methylation biomarker in AD. Eif2ak2 was involved in AD by modulating the synthesis of pro-inflammatory factors and virus defense in the brain (Carret-Rebillat et al., 2015) . Eif2ak2 was also regulated by DNA methylation between the two groups. The functional roles of DNA methylation in AD are highly complex and diverse. More efforts are needed to study the molecular mechanisms of these most likely DNA methylation sites. This endeavor will be an enormous challenge for many years to come.
To summarize, the DNA methylation profiles in SAMP8 mice brain provided evidence for further understanding of their regulatory roles in AD pathogenesis. DNA methylation has become a potential therapeutic target for many diseases because of its reversibility. Based on our results, these novel methylation sites could be regarded as new biomarkers or targets in AD, which may play significant roles in early diagnosis and clinical treatment. Regardless of these results, we identified modest DNA methylation differences as an important event in AD.
